Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.494 EUR
−254.83 M EUR
52.66 M EUR
93.63 M
About CureVac N.V.
Sector
CEO
Alexander Zehnder
Headquarters
Tübingen
Website
Founded
2020
ISIN
NL0015436031
FIGI
BBG01HQ1XB81
CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy. The company was founded by Ingmar Hoerr and Florian von der Mülbe in 2000 and is headquartered in Tübingen, Germany.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4CVAC is 2.632 EUR — it has increased by 8.85% in the past 24 hours. Watch CUREVAC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EUROTLX exchange CUREVAC stocks are traded under the ticker 4CVAC.
4CVAC stock has risen by 5.30% compared to the previous week, the month change is a 1.89% rise, over the last year CUREVAC has showed a −47.78% decrease.
We've gathered analysts' opinions on CUREVAC future price: according to them, 4CVAC price has a max estimate of 15.11 EUR and a min estimate of 2.36 EUR. Watch 4CVAC chart and read a more detailed CUREVAC stock forecast: see what analysts think of CUREVAC and suggest that you do with its stocks.
4CVAC reached its all-time high on Nov 30, 2021 with the price of 42.080 EUR, and its all-time low was 2.128 EUR and was reached on Apr 25, 2024. View more price dynamics on 4CVAC chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4CVAC stock is 1.82% volatile and has beta coefficient of 1.32. Track CUREVAC stock price on the chart and check out the list of the most volatile stocks — is CUREVAC there?
Today CUREVAC has the market capitalization of 568.63 M, it has increased by 1.42% over the last week.
Yes, you can track CUREVAC financials in yearly and quarterly reports right on TradingView.
CUREVAC is going to release the next earnings report on Apr 23, 2025. Keep track of upcoming events with our Earnings Calendar.
4CVAC earnings for the last quarter are 1.51 EUR per share, whereas the estimation was 1.41 EUR resulting in a 7.09% surprise. The estimated earnings for the next quarter are −0.21 EUR per share. See more details about CUREVAC earnings.
CUREVAC revenue for the last quarter amounts to 493.90 M EUR, despite the estimated figure of 3.35 M EUR. In the next quarter, revenue is expected to reach 6.50 M EUR.
4CVAC net income for the last quarter is 333.53 M EUR, while the quarter before that showed −72.91 M EUR of net income which accounts for 557.45% change. Track more CUREVAC financial stats to get the full picture.
No, 4CVAC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 26, 2024, the company has 1.17 K employees. See our rating of the largest employees — is CUREVAC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CUREVAC EBITDA is 185.29 M EUR, and current EBITDA margin is −473.93%. See more stats in CUREVAC financial statements.
Like other stocks, 4CVAC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CUREVAC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CUREVAC technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CUREVAC stock shows the sell signal. See more of CUREVAC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.